199 related articles for article (PubMed ID: 37980859)
1. Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance.
Zhu Y; Xia T; Chen DQ; Xiong X; Shi L; Zuo Y; Xiao H; Liu L
Drug Resist Updat; 2024 Jan; 72():101016. PubMed ID: 37980859
[TBL] [Abstract][Full Text] [Related]
2. Protein arginine methyltransferases (PRMTs): Orchestrators of cancer pathogenesis, immunotherapy dynamics, and drug resistance.
Gao Y; Feng C; Ma J; Yan Q
Biochem Pharmacol; 2024 Mar; 221():116048. PubMed ID: 38346542
[TBL] [Abstract][Full Text] [Related]
3. A patent review of arginine methyltransferase inhibitors (2010-2018).
Li X; Wang C; Jiang H; Luo C
Expert Opin Ther Pat; 2019 Feb; 29(2):97-114. PubMed ID: 30640571
[TBL] [Abstract][Full Text] [Related]
4. Protein arginine methylation: from enigmatic functions to therapeutic targeting.
Wu Q; Schapira M; Arrowsmith CH; Barsyte-Lovejoy D
Nat Rev Drug Discov; 2021 Jul; 20(7):509-530. PubMed ID: 33742187
[TBL] [Abstract][Full Text] [Related]
5. Protein arginine methyltransferases: promising targets for cancer therapy.
Hwang JW; Cho Y; Bae GU; Kim SN; Kim YK
Exp Mol Med; 2021 May; 53(5):788-808. PubMed ID: 34006904
[TBL] [Abstract][Full Text] [Related]
6. PRMT blockade induces defective DNA replication stress response and synergizes with PARP inhibition.
Li Y; Dobrolecki LE; Sallas C; Zhang X; Kerr TD; Bisht D; Wang Y; Awasthi S; Kaundal B; Wu S; Peng W; Mendillo ML; Lu Y; Jeter CR; Peng G; Liu J; Westin SN; Sood AK; Lewis MT; Das J; Yi SS; Bedford MT; McGrail DJ; Sahni N
Cell Rep Med; 2023 Dec; 4(12):101326. PubMed ID: 38118413
[TBL] [Abstract][Full Text] [Related]
7. Non-Histone Arginine Methylation by Protein Arginine Methyltransferases.
Al-Hamashi AA; Diaz K; Huang R
Curr Protein Pept Sci; 2020; 21(7):699-712. PubMed ID: 32379587
[TBL] [Abstract][Full Text] [Related]
8. An updated patent review of protein arginine N-methyltransferase inhibitors (2019-2022).
Dong J; Duan J; Hui Z; Garrido C; Deng Z; Xie T; Ye XY
Expert Opin Ther Pat; 2022 Dec; 32(12):1185-1205. PubMed ID: 36594709
[TBL] [Abstract][Full Text] [Related]
9. Small Molecule Inhibitors of Protein Arginine Methyltransferases.
Hu H; Qian K; Ho MC; Zheng YG
Expert Opin Investig Drugs; 2016; 25(3):335-58. PubMed ID: 26789238
[TBL] [Abstract][Full Text] [Related]
10. Arginine methylation: the promise of a 'silver bullet' for brain tumours?
Samuel SF; Barry A; Greenman J; Beltran-Alvarez P
Amino Acids; 2021 Apr; 53(4):489-506. PubMed ID: 33404912
[TBL] [Abstract][Full Text] [Related]
11. PRMTs and Arginine Methylation: Cancer's Best-Kept Secret?
Jarrold J; Davies CC
Trends Mol Med; 2019 Nov; 25(11):993-1009. PubMed ID: 31230909
[TBL] [Abstract][Full Text] [Related]
12. Functional Study of
Lorenzon L; Quilles JC; Campagnaro GD; Azevedo Orsine L; Almeida L; Veras F; Miserani Magalhães RD; Alcoforado Diniz J; Rodrigues Ferreira T; Kaysel Cruz A
ACS Infect Dis; 2022 Mar; 8(3):516-532. PubMed ID: 35226477
[TBL] [Abstract][Full Text] [Related]
13. The macromolecular complexes of histones affect protein arginine methyltransferase activities.
Fulton MD; Cao M; Ho MC; Zhao X; Zheng YG
J Biol Chem; 2021 Oct; 297(4):101123. PubMed ID: 34492270
[TBL] [Abstract][Full Text] [Related]
14. Type I and II PRMTs inversely regulate post-transcriptional intron detention through Sm and CHTOP methylation.
Maron MI; Casill AD; Gupta V; Roth JS; Sidoli S; Query CC; Gamble MJ; Shechter D
Elife; 2022 Jan; 11():. PubMed ID: 34984976
[TBL] [Abstract][Full Text] [Related]
15. Flavokawain A is a natural inhibitor of PRMT5 in bladder cancer.
Liu S; Liu Z; Piao C; Zhang Z; Kong C; Yin L; Liu X
J Exp Clin Cancer Res; 2022 Oct; 41(1):293. PubMed ID: 36199122
[TBL] [Abstract][Full Text] [Related]
16. Identification of hnRNP-A1 as a pharmacodynamic biomarker of type I PRMT inhibition in blood and tumor tissues.
Noto PB; Sikorski TW; Zappacosta F; Wagner CD; Montes de Oca R; Szapacs ME; Annan RS; Liu Y; McHugh CF; Mohammad HP; Piccoli SP; Creasy CL
Sci Rep; 2020 Dec; 10(1):22155. PubMed ID: 33335114
[TBL] [Abstract][Full Text] [Related]
17. Arginine Methylation: The Coming of Age.
Blanc RS; Richard S
Mol Cell; 2017 Jan; 65(1):8-24. PubMed ID: 28061334
[TBL] [Abstract][Full Text] [Related]
18. Assaying epigenome functions of PRMTs and their substrates.
Rakow S; Pullamsetti SS; Bauer UM; Bouchard C
Methods; 2020 Mar; 175():53-65. PubMed ID: 31542509
[TBL] [Abstract][Full Text] [Related]
19. Protein Arginine Methylation: An Emerging Modification in Cancer Immunity and Immunotherapy.
Dai W; Zhang J; Li S; He F; Liu Q; Gong J; Yang Z; Gong Y; Tang F; Wang Z; Xie C
Front Immunol; 2022; 13():865964. PubMed ID: 35493527
[TBL] [Abstract][Full Text] [Related]
20. The regulation, functions and clinical relevance of arginine methylation.
Guccione E; Richard S
Nat Rev Mol Cell Biol; 2019 Oct; 20(10):642-657. PubMed ID: 31350521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
